Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration (Q81773143)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

6

Thomas M Kündig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Barbara R von Beust

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Pål Johansen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Kent A Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Adrian Bot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Tazio Storni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

1869-1876

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

CpG motifs in bacterial DNA and their immune effects

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Toll meets bacterial CpG-DNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Immunotherapeutic uses of CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

CpG-DNA upregulates the major acute-phase proteins SAA and SAP.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Lymphokine production by human T cells in disease states

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526124

7 January 2021

Identifiers

DOI

10.1002/EJI.200526124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15909311%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference